Solvay

Investment decisions are split across two layers. The family's primary listed holding vehicle, Solvac S.A., oversees the aggregated stake in the operating companies. At the operating-company level, Solvay Ventures and Syensqo Ventures Fund deploy venture capital into material-science and energy-transition startups. The CEO of each operating company—Philippe Kehren at Solvay and Ilham Kadri at Syensqo—oversees deployment, with board oversight from family representatives including Chairman Nicolas Boël. (public record)

The family does not operate a standalone single family office in the modern private-markets sense. Instead, Solvac S.A. functions as a publicly listed holding company that consolidates the descendants' stake in the two operating companies. This structure provides a liquidity mechanism for family members while preserving a unified control block—a Belgian model that blends elements of a family office with the governance obligations of a listed entity. (public record)

In December 2023, Solvay split into two independent publicly listed companies. Solvay SA retained the essential chemicals portfolio—soda ash, peroxides, silica, and coatings—while Syensqo absorbed the specialty businesses including polymers, composites, and consumer products. The separation allowed the family to separate commodity-margin exposure from higher-growth specialty exposure while retaining significant influence over both entities. (per the firm, December 2023)

Yes, through its corporate venture capital vehicles. Solvay Ventures and Syensqo Ventures Fund invest in early-stage companies focused on advanced materials, renewable chemistry, and the energy transition. These are balance-sheet-backed funds that operate with venture-style mandates, sourcing deals from university spinouts, incubators, and industrial-tech ecosystems. (per the firm's official communications)

The Boël family became linked to the Solvay dynasty through marriage and joint stewardship of the industrial group over multiple generations. Nicolas Boël, a descendant of that aligned branch, currently serves as Chairman of the Board of Directors of Solvay, reflecting how the two families have interwoven their governance roles and economic interests across more than a century. (public record)

Yes. The family sustains a significant philanthropic legacy through vehicles including the Ernest Solvay Fund, the Solvay Solidarity Fund, and the International Solvay Institutes for Physics and Chemistry. The latter, established in 1912, have hosted some of the most consequential scientific conferences in modern physics—an enduring institutional contribution separate from the commercial enterprise. (public record)

The dominant share is structurally tied to the two operating companies through the Solvac S.A. holding. However, the family also holds significant historical real estate assets, including the Victor Horta-designed Hôtel Solvay in Brussels and the Château de La Hulpe estate. The corporate venture arms create an additional, growth-oriented pocket of deployment separate from the core industrial balance sheet. (public record)